Total Payments
$2,084
2022 Payments
$350.96
Companies
25
Transactions
114
Medicare Patients
2,856
Medicare Billing
$330,345
Payment Breakdown by Category
Food & Beverage$2,072 (99.4%)
Other$11.69 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,072 | 113 | 99.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11.69 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $539.80 | 42 | $0 (2022) |
| Amgen Inc. | $438.67 | 7 | $0 (2022) |
| Lilly USA, LLC | $203.12 | 12 | $0 (2022) |
| Allergan, Inc. | $106.64 | 7 | $0 (2020) |
| ABBVIE INC. | $101.83 | 7 | $0 (2022) |
| Mitsubishi Tanabe Pharma America, Inc. | $93.00 | 1 | $0 (2018) |
| EMD Serono, Inc. | $83.71 | 6 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $78.96 | 4 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $70.53 | 5 | $0 (2019) |
| UCB, Inc. | $70.06 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $350.96 | 13 | Amgen Inc. ($142.31) |
| 2021 | $203.43 | 12 | Novartis Pharmaceuticals Corporation ($61.81) |
| 2020 | $236.05 | 8 | Amgen Inc. ($125.00) |
| 2019 | $457.12 | 28 | Supernus Pharmaceuticals, Inc. ($204.71) |
| 2018 | $415.40 | 25 | Supernus Pharmaceuticals, Inc. ($135.23) |
| 2017 | $420.78 | 28 | Supernus Pharmaceuticals, Inc. ($125.03) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $27.96 | General |
| Category: NEUROLOGY | ||||||
| 09/21/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Neuroscience | ||||||
| 08/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuroscience | ||||||
| 05/11/2022 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Neuroscience | ||||||
| 04/20/2022 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: AED | ||||||
| 03/30/2022 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $20.22 | General |
| Category: AED | ||||||
| 03/03/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Neuroscience | ||||||
| 02/02/2022 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $17.68 | General |
| Category: AED | ||||||
| 01/12/2022 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: NEUROLOGY | ||||||
| 10/20/2021 | UPSHER-SMITH LABORATORIES LLC | TOSYMRA (Drug), ZEMBRACE SYMTOUCH, QUDEXY | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: NEUROLOGY | ||||||
| 10/13/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: PRIMARY CARE | ||||||
| 08/18/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: NEUROLOGY | ||||||
| 07/14/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Neuroscience | ||||||
| 05/25/2021 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Neuroscience | ||||||
| 04/21/2021 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2021 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 375 | 521 | $140,720 | $53,876 |
| 2022 | 15 | 571 | 867 | $190,810 | $68,953 |
| 2021 | 22 | 1,288 | 2,204 | $732,897 | $126,101 |
| 2020 | 10 | 622 | 917 | $216,540 | $81,415 |
Total Patients
2,856
Total Services
4,509
Medicare Billing
$330,345
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 147 | $38,955 | $13,061 | 33.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 61 | 61 | $28,975 | $9,991 | 34.5% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 43 | 48 | $26,880 | $8,592 | 32.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 49 | 110 | $21,450 | $8,154 | 38.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 23 | 23 | $9,775 | $6,508 | 66.6% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 28 | 33 | $6,600 | $3,344 | 50.7% |
| 96133 | Evaluation of neuropsychological test, each additional hour | Office | 2023 | 28 | 33 | $4,620 | $2,527 | 54.7% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2023 | 28 | 33 | $1,815 | $861.63 | 47.5% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 28 | 33 | $1,650 | $836.88 | 50.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 167 | $44,255 | $15,668 | 35.4% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 44 | 49 | $27,440 | $9,414 | 34.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 58 | 58 | $27,550 | $8,723 | 31.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 48 | 105 | $20,475 | $8,125 | 39.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 25 | 25 | $10,625 | $7,361 | 69.3% |
| 95937 | Testing of nerve-muscle junction | Facility | 2022 | 47 | 137 | $14,796 | $3,823 | 25.8% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2022 | 33 | 36 | $7,200 | $3,532 | 49.1% |
| 96133 | Evaluation of neuropsychological test, each additional hour | Office | 2022 | 34 | 37 | $5,180 | $2,822 | 54.5% |
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 2022 | 17 | 70 | $7,119 | $1,848 | 26.0% |
| 95939 | Placement of skin electrodes and measurement of central motor stimulation in arms and legs | Facility | 2022 | 17 | 17 | $6,334 | $1,621 | 25.6% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2022 | 35 | 35 | $5,026 | $1,280 | 25.5% |
| 95861 | Needle measurement of electrical activity in arm or leg muscles, 2 extremities | Facility | 2022 | 17 | 17 | $4,372 | $1,119 | 25.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 15 | 30 | $4,299 | $1,097 | 25.5% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2022 | 33 | 36 | $1,980 | $966.60 | 48.8% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2022 | 33 | 36 | $1,800 | $948.06 | 52.7% |
| 95868 | Needle measurement of electrical activity in muscles on both sides of body | Facility | 2022 | 12 | 12 | $2,359 | $603.12 | 25.6% |
About Dr. Richard Boehme, MD
Dr. Richard Boehme, MD is a Neurology healthcare provider based in Jacksonville Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245227800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Boehme, MD has received a total of $2,084 in payments from pharmaceutical and medical device companies, with $350.96 received in 2022. These payments were reported across 114 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,072).
As a Medicare-enrolled provider, Boehme has provided services to 2,856 Medicare beneficiaries, totaling 4,509 services with total Medicare billing of $330,345. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Jacksonville Beach, FL
- Active Since 09/29/2005
- Last Updated 12/29/2011
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1245227800
Products in Payments
- TROKENDI XR (Drug) $539.80
- Aimovig (Biological) $426.20
- EMGALITY (Drug) $166.21
- Radicava (Drug) $93.00
- UBRELVY (Drug) $74.33
- NUEDEXTA (Drug) $70.53
- Briviact (Drug) $70.06
- AIMOVIG (Biological) $61.81
- NAMZARIC (Drug) $49.99
- QULIPTA (Drug) $43.55
- Rebif (Biological) $40.68
- AMYVID (Drug) $36.91
- AUBAGIO (Drug) $29.86
- Mavenclad (Drug) $28.30
- VYEPTI (Biological) $27.96
- OCREVUS (Biological) $26.97
- BOTOX (Biological) $26.92
- Gralise (Drug) $25.14
- TOSYMRA (Drug) $18.20
- RYTARY (Drug) $18.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Jacksonville Beach
Thomas Snyder, Md, MD
Neurology — Payments: $340,171
Neurology $340,171
Dr. Robert Mannel, M.d, M.D
Neurology — Payments: $52,844
Neurology $52,844
Dr. Christine Pierre, Md, MD
Neurology — Payments: $11,122
Neurology $11,122
Dr. Michael Todinca, M.d, M.D
Neurology — Payments: $4,512
Neurology $4,512
Dr. Michelle Nunes Caravaglio, Md, MD
Neurology — Payments: $2,734
Neurology $2,734
Dr. Karen Thalinger, Md, MD
Neurology — Payments: $950.12
Neurology $950.12